Decision making in men with newly diagnosed favourable-risk prostate cancer is driven by magnetic resonance imaging (MRI) and post-MRI biopsy, according to a study, noting that post-MRI biopsy is a stronger driver of decision making than MRI alone.
The dorsal penile nerve branches are thicker in men with lifelong premature ejaculation (PE), according to a recent China study. Selective dorsal neurectomy (SDN) is effective in these patients, improving intravaginal ejaculatory latency time (IELT) and ejaculation controllability.
Radiotherapy in parallel with panitumumab use following induction chemotherapy and pelvic lymph node dissection appears to be well tolerated and is noninferior to the historical profile of concurrent radiotherapy and cisplatin, a study has shown.
A contraceptive vaginal system (Annovera) releasing a combination of segesterone acetate and ethinyl estradiol (SA/EE) effectively inhibits ovulation up to a year even at low systemic levels of SA, reports a review study presented at ENDO 2019.
Men with advanced prostate cancer who have pre-existing cardiovascular disease (CVD) may have an elevated mortality risk after treatment with abiraterone acetate compared with men who do not have CVD, according to a study presented at AACR 2019.